TY - JOUR
T1 - Benchtop Proton NMR Spectroscopy for High-Throughput Lipoprotein Quantification in Human Serum and Plasma
AU - Wist, Julien
AU - Nitschke, Philipp
AU - Conde, Ricardo
AU - de Diego, Angela
AU - Bizkarguenaga, Maider
AU - Lodge, Samantha
AU - Hall, Drew
AU - Chai, Zhonglin
AU - Wang, Wenjun
AU - Kowlessur, Sudhir
AU - Cobo, Marcio Fernando
AU - Pompe, Niels
AU - Schütz, Birk
AU - Schäfer, Hartmut
AU - Spraul, Manfred
AU - Cannet, Claire
AU - Diercks, Tammo
AU - Embade, Nieves
AU - Holmes, Elaine
AU - Millet, Oscar
AU - Nicholson, Jeremy K.
N1 - Publisher Copyright:
© 2025 The Authors. Published by American Chemical Society.
PY - 2025/4/1
Y1 - 2025/4/1
N2 - We report the successful development and translation of high-field nuclear magnetic resonance (NMR) based comprehensive lipoprotein analysis to routine benchtop systems. This demonstrates the potential to reimagine population level cardiovascular disease risk analysis and individual level screening based on blood sampling. Using a quantitative calibration approach, we obtained stable and reproducible results from multiple sites, despite reduced spectral dispersion and sensitivity at lower field strengths. Our study shows that 25 out of 28 major lipoprotein parameters, including key cardiometabolic risk markers, were faithfully measured using benchtop NMR systems within 15 min. This development has significant implications for making a powerful diagnostic tool widely available, enhancing the potential for longitudinal personalized medicine through molecular phenotyping in the clinic.
AB - We report the successful development and translation of high-field nuclear magnetic resonance (NMR) based comprehensive lipoprotein analysis to routine benchtop systems. This demonstrates the potential to reimagine population level cardiovascular disease risk analysis and individual level screening based on blood sampling. Using a quantitative calibration approach, we obtained stable and reproducible results from multiple sites, despite reduced spectral dispersion and sensitivity at lower field strengths. Our study shows that 25 out of 28 major lipoprotein parameters, including key cardiometabolic risk markers, were faithfully measured using benchtop NMR systems within 15 min. This development has significant implications for making a powerful diagnostic tool widely available, enhancing the potential for longitudinal personalized medicine through molecular phenotyping in the clinic.
UR - https://www.scopus.com/pages/publications/105001807633
U2 - 10.1021/acs.analchem.4c04660
DO - 10.1021/acs.analchem.4c04660
M3 - Article
C2 - 40095953
AN - SCOPUS:105001807633
SN - 0003-2700
VL - 97
SP - 6399
EP - 6409
JO - Analytical Chemistry
JF - Analytical Chemistry
IS - 12
ER -